Selective Institutional Bets Emerge in Medical and Tech NichesGlobal Report·Oct 21, 2026 at 10:15 AMBSL+0.08%BSEM+2.44%
BioStem wins US patent for sterile human placental allografts, methods of making themPUBT·Oct 1, 2026 at 11:02 AMBSEM+2.44%
BioStem Technologies Secures $3 Million Private Placement; Issues Stock at $4.08 and WarrantsTradingView·Sep 30, 2026 at 08:53 PMBSEM+2.44%
BioStem Technologies prices USD 3 million at-the-market private placement under Nasdaq rulesPUBT·Sep 30, 2026 at 12:04 PMBSEM+2.44%
BioStem Technologies joins Terminal1 investor relations platformPUBT·Sep 21, 2026 at 08:31 PMBSEM+2.44%
BioStem Technologies files to sell 12.05M shares of common stock for holdersbusinessinsider·Sep 19, 2026 at 03:49 AMBSEM+2.44%
BioStem Technologies Establishes $40 Million Committed Equity Facility With Roth Principal InvestmentsTradingView·Sep 18, 2026 at 08:33 PMBSEM+2.44%
12 Health Care Stocks Moving In Friday's Intraday Sessionbenzinga_article·Sep 18, 2026 at 05:05 PMNUWE-5.08%XENE-0.88%
BioStem secures USD 40 million equity facility via private placement with Roth affiliatePUBT·Sep 18, 2026 at 11:00 AMBSEM+2.44%
BioStem Technologies Opens Hospital Access for VENDAJE® and VENDAJE AC® Through Vizient and Premier | BSEM Stock NewsStockTitan·Sep 4, 2026 at 03:00 AMBSEM+2.44%PINC-0.10%